GGrantIndex
← Search

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

$115,334N01FY2024DANIH

Iit Research Institute, Chicago IL

Investigators

View original record on NIH RePORTER →